<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Korzets Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Menstrual and parity history might impact the risk for breast cancer. Data on the impact of these factors on other tumor characteristics are limited.&lt;h4>Methods&lt;/h4>A single center retrospective cohort study comprising all women with estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative, early breast cancer whose tumors were sent to OncotypeDX analysis. The prespecified subgroups were investigated: age of menarche (&lt; 12 vs. ≥ 12 years), number of deliveries (0 vs. ≥ 1 childbirth and ≥ 5 childbirth vs. other), age of first delivery (≥ 30 years vs. younger age) and postmenopausal compared to premenopausal. The impact of age of menopause was also assessed categorically, using early (&lt; 45 years) and late age of menopause (> 55 years). Diff</pubmed_abstract><journal>Discover. Oncology</journal><pagination>26</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8777527</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer.</pubmed_title><pmcid>PMC8777527</pmcid><pubmed_authors>Mutai R</pubmed_authors><pubmed_authors>Shochat T</pubmed_authors><pubmed_authors>Moore A</pubmed_authors><pubmed_authors>Korzets Y</pubmed_authors><pubmed_authors>Yariv O</pubmed_authors><pubmed_authors>Goldvaser H</pubmed_authors><pubmed_authors>Yerushalmi R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer.</name><description>&lt;h4>Background&lt;/h4>Menstrual and parity history might impact the risk for breast cancer. Data on the impact of these factors on other tumor characteristics are limited.&lt;h4>Methods&lt;/h4>A single center retrospective cohort study comprising all women with estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative, early breast cancer whose tumors were sent to OncotypeDX analysis. The prespecified subgroups were investigated: age of menarche (&lt; 12 vs. ≥ 12 years), number of deliveries (0 vs. ≥ 1 childbirth and ≥ 5 childbirth vs. other), age of first delivery (≥ 30 years vs. younger age) and postmenopausal compared to premenopausal. The impact of age of menopause was also assessed categorically, using early (&lt; 45 years) and late age of menopause (> 55 years). Diff</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-18T17:08:54.301Z</modification><creation>2025-04-07T04:44:02.083Z</creation></dates><accession>S-EPMC8777527</accession><cross_references><pubmed>35201434</pubmed><doi>10.1007/s12672-021-00420-x</doi></cross_references></HashMap>